Clinical and Functional Outcome of the GEMINI SL Fixed Bearing PS Knee Prosthesis

January 11, 2023 updated by: Waldemar Link GmbH & Co. KG

Clinical and Functional Outcome of the GEMINI SL Fixed Bearing PS Knee Prosthesis in Short-, Mid-, and Longterm Follow-up

This is a prospective, multicenter, observational study with a planned follow-up period of 10 years to confirm the safety and performance of the GEMINI SL Fixed Bearing PS knee prosthesis in longterm follow-up under routine conditions. Primary outcome of the study is the 10-year survival rate of the GEMINI SL Fixed Bearing PS knee prosthesis with revision for any reason as the endpoint.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The GEMINI SL Fixed Bearing PS knee prosthesis combines clinical proven design features with state-of-the-art-technology in order to achieve a high standard clinical performance, surgical efficiency and safety. Currently, no mid- and longterm clinical data are available for the GEMINI SL Fixed Bearing PS knee prosthesis. Therefore, the study is designed to generate clinical data of the GEMINI SL Fixed Bearing PS knee prosthesis in the 10-year follow-up under routine condition.

Study Type

Observational

Enrollment (Anticipated)

350

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Valle Del Cauca
      • Cali, Valle Del Cauca, Colombia
        • Recruiting
        • Centro Medico Imbanaco Sede Principal
        • Contact:
        • Principal Investigator:
          • Julio Cesar Palacio Villegas, Dr.
        • Sub-Investigator:
          • Daniel Carvajal, Dr.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients who are scheduled for an implantation of the GEMINI SL Fixed Bearing PS knee prosthesis are potential study participants. The decision about the surgical treatment and the use of the GEMINI SL Fixed Bearing PS knee prosthesis is made by the treating surgeons and depends on Link Gemini SL Fixed Bearing PS _ Colombia Version 1.0 vom 24.08.2018 Seite 12 von 19 the clinical findings of the patient. The potential study participation is independent from the therapy decision.

Description

Inclusion Criteria:

  • Signed patient informed consent
  • Implantation of a GEMINI SL Fixed Bearing PS knee prosthesis
  • Age between 18 and 80 years

Exclusion Criteria:

  • Body Mass Index (BMI) > 40 kg/m²
  • Foreseeable life expectancy under 5 years
  • Comorbidities and known medical circumstances which would affect the clinical or functional outcome after implantation of the knee prosthesis (e.g. neurological or musculoskeletal diseases) at the time of implantation
  • Patient who is mentally not able to understand the study and the study conduct
  • Patients who will be foreseeable non-compliant to the planned routine interventions and study related follow-ups
  • Prisoner
  • Pregnant women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
10-year survival rate of the Gemini SL Fixed Bearing PS knee prothesis
Time Frame: 10 years
Primary outcome of the study is the 10-year survival rate of the Gemini SL Fixed Bearing PS knee prosthesis with revision for any reason as the endpoint. Revisions are defined as removal, exchange or adding of any implant components. The definition does not include subsequent implantations or exchange of the patella component or the polyethylene plateau. Survival rate will be calculated according to the method of Kaplan-Meier.
10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survival rate of the GEMINI SL Fixed Bearing PS knee prosthesis
Time Frame: after 6 months, 1,3 and 5 years
Survival rate of the GEMINI SL Fixed Bearing PS knee prosthesis after 6 months, 1, 3 and 5 years
after 6 months, 1,3 and 5 years
Change in functional and clinical outcome (KOOS)
Time Frame: preoperative examination to postoperative examinations after 6 months, 1, 3, 5 and 10 years
Evaluation of the change in functional and clinical outcome from preoperative to 6 months, 1, 3, 5 and 10 years postoperative, measured by the Knee injury and Osteoarthritis Outcome Score (KOOS). The KOOS is a reliable and validated knee-specific patient-administered outcome instrument. The previous week is taken into consideration when answering the questions. Standardized answer options are given (5 Likert boxes) and each question gets a score from 0 (best result) to 4 (worst result). The KOOS consists of 5 sub-scales: Pain, Symptoms, Function in daily living (ADL), Function in sport and recreation (Sport/Rec) and Hip/Knee related Quality of life (QoL). A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.
preoperative examination to postoperative examinations after 6 months, 1, 3, 5 and 10 years
Change in functional and clinical outcome (KSS)
Time Frame: preoperative examination to postoperative examinations after 6 months, 1, 3, 5 and 10 years
Evaluation of the change in functional and clinical outcome from preoperative to 6 months, 1, 3, 5 and 10 years postoperative, measured by the Knee Society Score (KSS). The KSS is a frequently used, reliable and validated score in the assessment of a subject's knee pain and functional knee capacity. It comprises two arms, the functional ability and the clinical examination score, each ranging from 0 points (worst result) to 100 points (best result).
preoperative examination to postoperative examinations after 6 months, 1, 3, 5 and 10 years
Complications rate
Time Frame: Intraoperative examinations to 10-year follow-up examination
Complications related to implantation of the GEMINI SL Fixed Bearing PS knee prosthesis (infections, dislocations, migrations, aseptic loosenings, periprosthetic fractures, intra-operative fractures, implant fractures, soft tissue fractures, joint instability etc.) will be recorded at all follow-up examinations.
Intraoperative examinations to 10-year follow-up examination
Subsequent surgical interventions
Time Frame: postoperative examinations up to 10-year follow-up examination
All subsequent surgical interventions at the operated knee (exchange of the polyethylene plateau, additional implantation/exchange of the patella component, soft-tissue balancing, debridement etc) will be recorded at all follow-up examinations.
postoperative examinations up to 10-year follow-up examination

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Julio Cesar Palacio Villegas, Dr., Centro Medico Imbanaco Sede Principal

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 4, 2019

Primary Completion (Anticipated)

October 1, 2034

Study Completion (Anticipated)

October 1, 2035

Study Registration Dates

First Submitted

April 14, 2021

First Submitted That Met QC Criteria

April 20, 2021

First Posted (Actual)

April 26, 2021

Study Record Updates

Last Update Posted (Actual)

January 12, 2023

Last Update Submitted That Met QC Criteria

January 11, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • KP11

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthrosis of Knee

Clinical Trials on Total knee replacement

Subscribe